NYSE · CI
Healthcare · Medical - Healthcare Plans
$282.43
Up+$1.40 (+0.50%)
Updated Oct 10, 2026, 5:47 PM
SID Score
7.3/10
Composite research score
Smart Money
56/100
Neutral
Price performance · CI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CI closed at $282.43 after 21 trading sessions, up 0.59% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $281.16 | $287.89 | $280.46 | $282.43 | 885.42K |
| Oct 8, 2026 | $278.98 | $282.4181 | $275.32 | $281.03 | 1.55M |
| Oct 7, 2026 | $274.88 | $283.125 | $274.76 | $278.51 | 1.63M |
| Oct 6, 2026 | $271.72 | $275.82 | $270.00 | $274.37 | 1.09M |
| Oct 5, 2026 | $270.00 | $273.11 | $266.455 | $271.29 | 1.54M |
| Oct 2, 2026 | $270.03 | $271.40 | $266.00 | $270.53 | 1.91M |
| Oct 1, 2026 | $275.97 | $275.97 | $262.85 | $267.96 | 1.98M |
| Sep 30, 2026 | $274.03 | $278.88 | $263.36 | $271.83 | 3.08M |
| Sep 29, 2026 | $269.97 | $276.61 | $269.01 | $275.26 | 1.98M |
| Sep 28, 2026 | $272.48 | $272.49 | $269.05 | $271.83 | 1.75M |
| Sep 25, 2026 | $266.13 | $273.36 | $265.35 | $272.01 | 1.82M |
| Sep 24, 2026 | $267.90 | $269.3333 | $263.755 | $265.50 | 1.61M |
| Sep 23, 2026 | $273.26 | $274.75 | $267.0192 | $268.27 | 1.83M |
| Sep 22, 2026 | $276.85 | $278.47 | $272.73 | $273.74 | 1.47M |
| Sep 21, 2026 | $275.91 | $275.91 | $272.621 | $274.47 | 1.39M |
| Sep 18, 2026 | $274.86 | $277.72 | $273.74 | $275.28 | 2.33M |
| Sep 17, 2026 | $280.83 | $281.405 | $275.76 | $276.00 | 1.17M |
| Sep 16, 2026 | $288.31 | $289.89 | $280.09 | $280.45 | 1.17M |
| Sep 15, 2026 | $289.90 | $290.715 | $286.715 | $288.90 | 1.26M |
| Sep 14, 2026 | $284.60 | $290.94 | $284.60 | $290.05 | 1.31M |
| Sep 11, 2026 | $283.01 | $285.00 | $277.51 | $280.76 | 1.34M |
The latest Smart Investors Daily articles mentioning CI.
Company
Market Activity
Research & News
CI research
Company profile and research snapshot.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 2, 2026 | Piper Sandler | Overweight | — |
| Oct 1, 2026 | RBC Capital | Outperform | — |
| Aug 4, 2026 | Jefferies | Hold | — |
| Aug 3, 2026 | Raymond James | Outperform | — |
| Jul 31, 2026 | Barclays | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Oct 2, 2026
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 1.05% on an annualized basis producing an average annual return of 10.13%. Currently, Cigna Group has a market capitalization of $71.48
Benzinga · Oct 2, 2026
Piper Sandler analyst Jessica Tassan maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $346 to $370.
Yahoo · Oct 1, 2026
Cigna (CI) is better positioned to achieve its long-term earnings-per-share growth goals, RBC Capita
Benzinga · Oct 1, 2026
RBC Capital analyst Ben Hendrix reiterates Cigna Group (NYSE:CI) with a Outperform and maintains $337 price target.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CI.
